Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Uncategorized

New Jersey Innovation Institute Introduces Two Groundbreaking Biopharmaceutical Centers

Newark, NJ, June 24, 2017 — Companies in every sector are realizing that manufacturing matters.  For the biopharmaceutical industry, innovation is not about reducing unit part costs; instead, process technology is a strategic tool to reduce time to market, ensure consistent product quality and streamline regulatory approval.

As rapidly as science is advancing drug discovery, so too, must production technology keep pace.  But where will such innovation happen?

The New Jersey Innovation Institute (NJII) is answering this question. Continue reading

Opinion: Labor Leader Greg Lalevee on ‘Workers Win When Jersey Drug Companies Innovate’

Greg Lalevee

Springfield, NJ, June 21, 2017The Record/NorthJersey.com on June 15 published the following opinion piece by Greg Lalevee, Business Manager, the International Union of Operating Engineers Local 825:

New Jersey’s nickname, “Medicine Chest of the World,” is backed up by the numbers.

Our state is home to more than 3,000 life sciences establishments.  Thirteen of the world’s top 20 biopharmaceutical companies have made the Garden State their U.S. headquarters.

These firms are innovating and saving lives every day — and they couldn’t do it without help from supportive government policies and New Jersey’s well-trained and talented union workforce. Continue reading

HINJ-Sponsored Event: NJCU Presidential Speaker Series Presents Dr. Bonnie Bassler at Liberty Science Center April 19

Jersey City, NJ, April 14, 2017 — The Liberty Science Center and New Jersey City University (NJCU) are pleased to present their third annual lecture on Wednesday, April 19.

With the success of physicist Dr. Michio Kaku in 2015 and planetary scientist Dr. Carolyn Porco in 2016, the two educational institutions have chosen the esteemed microbiologist Dr. Bonnie Bassler for this next lecture in the NJCU Presidential Speaker Series.

The HealthCare Institute of New Jersey (HINJ) is pleased to be one of the supporting organizations for this free lecture which is open to students, teachers, and the general public.   Continue reading

President Trump Leaves Science and Technology Jobs Vacant

President Donald Trump

Washington, DC, April 4, 2017 — Cecilia Kang and Michael D. Shear reported in The New York Times that on the fourth floor of the Eisenhower Executive Office Building, the staff of the White House chief technology officer has been virtually deleted, down from 24 members before the election to, by Friday, only one.

Scores of departures by scientists and Silicon Valley technology experts who advised President Trump’s predecessor have all but wiped out the larger White House Office of Science and Technology Policy.

President Trump has not yet named his top advisers on technology or science, and so far, has made just one hire: Michael Kratsios, the former chief of staff for Peter Thiel, the Silicon Valley investor and one of the president’s wealthiest supporters, as the deputy chief technology officer. Continue reading

Opinion: BIO CEO Jim Greenwood on ‘New Ways to Increase Patient Access to Needed Medications’

Jim Greenwood

Jim Greenwood

Washington, DC, January 10, 2017Biotechnology Innovation Organization (BIO) President and Chief Executive Officer James C. Greenwood writes in The Hill:

With a new year comes a new administration and a new Congress and a new opportunity to educate and inform stakeholders on the value of biopharmaceuticals and the biopharmaceutical industry.

It’s often forgotten that our uniquely American industry provides not only treatments and cures to sick patients, but also millions of good-paying jobs to Americans in practically every state. Continue reading

HHS Awards $ 19.8 Million to Takeda to Accelerate Development of a Zika Vaccine

Zika 3Washington, DC, September 4, 2016 — The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will provide an initial $19.8 million over the next 18 months to Takeda Vaccines, Inc. of Deerfield, Illinois, a subsidiary of the Takeda Group headquartered in Japan, to develop a Zika vaccine for use in the United States.

Under the contract, ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide funding to complete studies that should enable the company to file an Investigational New Drug application with the U.S. Food and Drug Administration.

If the application is approved, the first clinical (human) trials of the vaccine could begin next year. Continue reading

CDC Study Sheds Light on How Some Survive Ebola; Finding Points Way to New Approaches to Treatment

CDC LogoWashington, DC, July 1, 2016 ― A first-of-its-kind Ebola study yields clues to how some people are able to survive the deadly virus and suggests possible avenues for treatments that could save more lives.

Researchers at Centers for Disease Control and Prevention, Emory University School of Medicine, and University of Nebraska Medical Center analyzed the immune responses of Ebola patients treated in the United States.

Their study was recently published online in the Clinical Infectious Disease Journal in the article entitled, “Kinetic Analysis of Biomarkers in a Cohort of U.S. Patients with Ebola Virus Disease.” Continue reading

Vice President Biden Speaks on Cancer and Faith at the Vatican

Vice President Joe Biden

Vice President Joe Biden

Vatican City, May 2, 2016 ― Vice President Joseph R. Biden Jr. came to Vatican City to talk about two of his deepest passions: his Roman Catholic faith and curing cancer, Gardiner Harris reports in The New York Times.

At the Third International Regenerative Medicine Conference at the Vatican, Vice President Biden spoke about the urgent need to come up with new cures for cancer, a subject that has come to define his final year in office.

The conference is intended to highlight the extraordinary research advances being made with adult stem cells while largely sidestepping the issue of research using fetal tissue or embryonic stem cells.

“Most importantly, we want everyone to understand that no one has to choose between science and faith,” Dr. Robin Smith, president of the Stem for Life Foundation and one of the organizers of the three-day conference, said in a welcoming speech Tuesday. Continue reading

President Wants $1.9B to Fight Zika; Some House Republicans Are Unconvinced

Zika mosquitoWashington, DC, April 28, 2016 ― The Associated Press today reports that President Barack Obama’s $1.9 billion request for emergency money to combat the Zika virus has been sitting before Congress for more than two months—and there’s no obvious path forward despite a growing threat in the hot summer months and increasing public anxiety.

The administration has already transferred almost $600 million of unused Ebola funds and other money to fight Zika in the near term.  However, it says more is urgently needed to control the mosquitoes that spread the virus, manufacture vaccines once they are developed, and produce more accurate testing for the virus.

The Centers for Disease Control and Prevention said recently that no local mosquito-borne Zika virus disease cases have been reported in the U.S., but there have been 388 travel-associated cases. Continue reading

Christie Administration Recognizes Medical Laboratory Week

Cancer Research blueTrenton, NJ, April 26, 2016 ― New Jersey Acting Health Commissioner Cathleen Bennett recognizes National Medical Laboratory Professionals Week, April 24-30, by commending New Jersey’s laboratory professionals who play a vital part in every aspect of healthcare, including medical diagnosis and public health prevention.

“Every day, New Jersey’s laboratory professionals play a vital role in health care and especially in protecting the public’s health,” Acting Commissioner Bennett said.

“Laboratory professionals,” Bennett added, “work at commercial and hospital laboratories as well as the Department’s Public Health and Environmental Laboratory (PHEL) and conduct tests daily that help residents manage chronic disease, ensure drinking and recreational water is safe, detect and report disease outbreaks, and work closely with local, state and federal agencies in maintaining vigilance against bioterrorism.” Continue reading